DFDS A/S
| Company announcement no. 12/2021 |
In compliance with Article 19 of EU Regulation no. 596/2014, transactions are reported related to shares in DFDS A/S made by executives in DFDS and/or persons closely associated with them.
The transactions of Klaus Nyborg, Vice Chair of DFDS’ Board of Directors, are reported in the table below.
| Name | Klaus Nyborg |
| Position | Vice Chair |
| Issuer | DFDS |
| ID code | DK 0060655629 |
| Initial notification/ Amendment | Initial notification |
| Instrument | Shares |
| Transactions | Purchase of shares |
| Transaction date | 25 February 2021 |
| Price and volume | Purchase: 825 shares at a price of DKK 299.97 per share |
| Transaction values | Purchase: DKK 247k |
| Market | XCSE, Nasdaq Copenhagen |
Holding of shares by members of DFDS’ Board of Directors are available from this link
Contact
Torben Carlsen, CEO +45 33 42 32 01
Karina Deacon, CFO +45 33 42 33 42
Søren Brøndholt Nielsen, IR +45 33 42 33 59
Nicole Seroff, Communications +45 31 40 34 46
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
SkiStar AB13.12.2025 16:00:00 CET | Press release
Bulletin from Annual General Meeting of SkiStar AB
Robex Resources Inc.13.12.2025 06:31:43 CET | Press release
Robex Files Addendum to Information Circular in Connection With Amendment to Arrangement Agreement With Predictive Discovery
Teva Pharmaceutical Industries Ltd12.12.2025 22:30:00 CET | Press release
Teva Releases Q4 2025 Aide Memoire
Teva Pharmaceutical Industries Ltd12.12.2025 22:30:00 CET | Press release
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
Ingredion Incorporated12.12.2025 22:06:36 CET | Press release
Ingredion Incorporated Declares Quarterly Dividend of $0.82 Per Share
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
